Výsledky vyhledávání

Akademický článek

Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years.

Autor: Luger TA; Department of Dermatology, University Hospital Münster, Munster, Germany., Hebert AA; Department of Dermatology, UTHealth McGovern Medical School-Houston, 6655 Travis Street, Suite 980, Houston, TX, 77030, USA. Adelaide.A.Hebert@uth.tmc.edu., Zaenglein AL; Department of Dermatology, Pennsylvania State University, Hershey, PA, USA., Silverberg JI; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA., Tan H; Pfizer Inc., Groton, CT, USA., Ports WC; Pfizer Inc., Groton, CT, USA., Zielinski MA; Pfizer Inc., Collegeville, PA, USA.

Publikováno v: Paediatric drugs [Paediatr Drugs] 2022 Mar; Vol. 24 (2), pp. 175-183. Date of Electronic Publication: 2022 Mar 16.

Zobrazit plný text záznamu

Editorial & Opinion

Skin permeation and penetration of crisaborole when coapplied with emollients.

Autor: Draelos ZD; Dermatology Consulting Services, High Point, North Carolina. Electronic address: zdraelos@northstate.net., Ports WC; Pfizer Inc, Groton, Connecticut., Vlahos B; Pfizer Inc, Collegeville, Pennsylvania., Yeoh T; Pfizer Inc, Groton, Connecticut., Wu-Linhares D; Pfizer Inc, Groton, Connecticut., Brown MB; MedPharm Ltd, Guildford, United Kingdom., Lenn J; MedPharm Ltd, Durham, North Carolina., Thombre AG; Pfizer Inc, Groton, Connecticut.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2020 Dec; Vol. 83 (6), pp. 1801-1803. Date of Electronic Publication: 2020 Oct 14.

Zobrazit plný text záznamu

Akademický článek

Predictors of Systemic Exposure to Topical Crisaborole: A Nonlinear Regression Analysis.

Autor: Purohit V; Pfizer Inc, Groton, Connecticut, USA., Riley S; Pfizer Inc, Groton, Connecticut, USA., Tan H; Pfizer Inc, New York, New York, USA., Ports WC; Pfizer Inc, Groton, Connecticut, USA.

Publikováno v: Journal of clinical pharmacology [J Clin Pharmacol] 2020 Oct; Vol. 60 (10), pp. 1344-1354. Date of Electronic Publication: 2020 May 20.

Zobrazit plný text záznamu

Akademický článek

Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area.

Autor: Silverberg JI; Department of Dermatology, The George Washington University School of Medicine and Health Sciences, 20052 Washington, DC, USA. E-mail: JonathanISilverberg@gmail.com., Tallman AM, Ports WC, Gerber RA, Tan H, Zielinski MA

Publikováno v: Acta dermato-venereologica [Acta Derm Venereol] 2020 Jun 11; Vol. 100 (13), pp. adv00170. Date of Electronic Publication: 2020 Jun 11.

Zobrazit plný text záznamu

Akademický článek

Safety, Effectiveness, and Pharmacokinetics of Crisaborole in Infants Aged 3 to < 24 Months with Mild-to-Moderate Atopic Dermatitis: A Phase IV Open-Label Study (CrisADe CARE 1).

Autor: Schlessinger J; Advanced Skin Research Center, Skin Specialists PC, 2802 Oak View Dr, Omaha, NE, 68144, USA. skindoc@lovelyskin.com., Shepard JS; Ohio Pediatric Research Association, Dayton, OH, USA., Gower R; Marycliff Clinical Research, Spokane, WA, USA., Su JC; Department of Paediatrics, Murdoch Children's Research Institute, University of Melbourne, Melbourne, VIC, Australia.; Department of Dermatology, Monash University, Eastern Health, Melbourne, VIC, Australia., Lynde C; Department of Medicine, Lynde Institute for Dermatology, Markham, ON, Canada., Cha A; Pfizer Inc, New York, NY, USA., Ports WC; Global Product Development, Pfizer Inc, Groton, CT, USA., Purohit V; Global Product Development, Pfizer Inc, Groton, CT, USA., Takiya L; Medical Affairs, Pfizer Inc, Collegeville, PA, USA., Werth JL; Clinical Development and Operations, Pfizer Inc, Collegeville, PA, USA., Zang C; Biostatistics, Pfizer Inc, Collegeville, PA, USA., Vlahos B; Global Clinical Development, Pfizer Inc, Collegeville, PA, USA.

Publikováno v: American journal of clinical dermatology [Am J Clin Dermatol] 2020 Apr; Vol. 21 (2), pp. 275-284.

Zobrazit plný text záznamu

Akademický článek

Topical Agents for the Treatment of Atopic Dermatitis

Autor: Eichenfield LF, Luger T, Papp K, Silverberg JI, Sierka D, Zang C, Tallman AM, Zielinski, Ports WC

Publikováno v: Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2020 Jan 01; Vol. 19 (1), pp. 50-64.

Zobrazit plný text záznamu

Akademický článek

Phase 1 study of crisaborole in Japanese healthy volunteers and patients with atopic dermatitis.

Autor: Ono R; Clinical Pharmacology, Pfizer R&D Japan, Tokyo, Japan., Yagi M; OPHAC Hospital, Osaka, Japan., Shoji A; Department of Dermatology, Ikeda Kaisei Hospital, Osaka, Japan., Fujita K; Clinical Research, Pfizer R&D Japan, Tokyo, Japan., Yoshida M; Clinical Statistics, Pfizer R&D Japan, Tokyo, Japan., Ports WC; Inflammation & Immunology, Pfizer Inc., Groton, Connecticut, USA., Purohit VS; Clinical Pharmacology, Pfizer Inc., Groton, Connecticut, USA.

Publikováno v: The Journal of dermatology [J Dermatol] 2020 Jan; Vol. 47 (1), pp. 25-32. Date of Electronic Publication: 2019 Oct 27.

Zobrazit plný text záznamu

Akademický článek

Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial.

Autor: Bissonnette R; Innovaderm Research, Montreal, Quebec, Canada., Pavel AB; Department of Dermatology and Laboratory for Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY., Diaz A; Department of Dermatology and Laboratory for Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY; Ponce Health Sciences University School of Medicine, Ponce, Puerto Rico., Werth JL; Pfizer, Collegeville, Pa., Zang C; Pfizer, Collegeville, Pa., Vranic I; Pfizer, Surrey, United Kingdom., Purohit VS; Pfizer, Groton, Conn., Zielinski MA; Pfizer, Collegeville, Pa., Vlahos B; Pfizer, Collegeville, Pa., Estrada YD; Department of Dermatology and Laboratory for Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY., Saint-Cyr Proulx E; Innovaderm Research, Montreal, Quebec, Canada., Ports WC; Pfizer, Groton, Conn., Guttman-Yassky E; Department of Dermatology and Laboratory for Inflammatory Skin Diseases, Icahn School of Medicine at Mount Sinai, New York, NY. Electronic address: Emma.Guttman@mountsinai.org.

Publikováno v: The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2019 Nov; Vol. 144 (5), pp. 1274-1289. Date of Electronic Publication: 2019 Aug 13.

Zobrazit plný text záznamu

Akademický článek

Efficacy and Safety of Crisaborole Ointment, 2%, for the Treatment of Mild-to-Moderate Atopic Dermatitis Across Racial and Ethnic Groups.

Autor: Callender VD; Howard University College of Medicine, Washington, DC, USA. drcallender@CallenderSkin.com.; Callender Dermatology and Cosmetic Center, Glenn Dale, MD, USA. drcallender@CallenderSkin.com., Alexis AF; Mount Sinai St. Luke's and Mount Sinai West, New York, NY, USA.; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Stein Gold LF; Henry Ford Health System, Detroit, MI, USA., Lebwohl MG; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Paller AS; Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Desai SR; University of Texas Southwestern Medical Center, Dallas, TX, USA.; Innovative Dermatology, Plano, TX, USA., Tan H; Pfizer Inc., Groton, CT, USA., Ports WC; Pfizer Inc., Groton, CT, USA., Zielinski MA; Pfizer Inc., Collegeville, PA, USA., Tallman AM; Pfizer Inc., New York, NY, USA.

Publikováno v: American journal of clinical dermatology [Am J Clin Dermatol] 2019 Oct; Vol. 20 (5), pp. 711-723.

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání